Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06998433 · ClinicalTrials.gov registry record · Phase 4
Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia
A Phase 4 study, sponsored by Baylor College of Medicine.
- Not yet
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT06998433 is a Phase 4 study that has not yet begun recruiting, run by Baylor College of Medicine. The registered enrollment target is 56 participants.
The verdict
NCT06998433, a Phase 4 study, has not yet begun recruiting, sponsored by Baylor College of Medicine.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
This study aims to investigate whether platelet-rich plasma (PRP) injections can help treat central centrifugal cicatricial alopecia (CCCA), a type of scarring hair loss that mostly affects women of African descent. CCCA is a condition that leads to permanent hair loss, usually starting at the top of the scalp and spreading outward. It can also cause discomfort, such as itching, burning, and pain. The goal is to see if PRP, which comes from the patient's own blood and is thought to reduce inflammation and promote healing, can stop hair loss and even encourage hair regrowth. PRP has been used to treat other types of hair loss, but it has not been widely studied for CCCA. Participants in the study will be women of African descent who have been diagnosed with mild to moderate CCCA. Some participants will receive PRP injections, while others will receive a placebo (an inactive treatment) as part of a randomized, double-blind trial. All participants will continue using a topical steroid treatment, which is the standard of care for this condition. The study will also look at growth factors in participants' blood to understand how they may affect hair loss or regrowth. The goal is to gather information that could lead to better treatments for CCCA, a condition that currently has no standard treatment guidelines. Although there are risks such as minor discomfort from blood draws and scalp injections and/or a small risk of disease progression, the potential benefits include improved hair growth and a better understanding of CCCA treatments.
Interventions
- DRUG Saline
- BIOLOGICAL Platelet-Rich Plasma (PRP) Injections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06998433
The ClinicalTrials.gov registry entry for NCT06998433 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT06998433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06998433 about?
NCT06998433 is a clinical study titled "Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia". This study aims to investigate whether platelet-rich plasma (PRP) injections can help treat central centrifugal cicatricial alopecia (CCCA), a type of scarring hair loss that mostly affects women of African descent. CCCA is a condition that leads to permanent hair loss, usually starting at the top o...
What is the current status of trial NCT06998433?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2025-09-30. Estimated completion is 2026-07-31.
What interventions are being tested in trial NCT06998433?
The interventions under investigation include: Saline (DRUG), Platelet-Rich Plasma (PRP) Injections (BIOLOGICAL).
Who is sponsoring clinical trial NCT06998433?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.